Increased Toll-Like Receptor 2 Expression in Peptidoglycan-Treated Blood Monocytes Is Associated with Insulin Resistance in Patients with Nondiabetic Rheumatoid Arthritis

The close relationship between increased TLR-2 expression in blood monocytes and insulin resistance in RA patients is shown in this study. Traditional risk factors for metabolic disorders, including the waist circumstance, body mass index (BMI), triglyceride (TG), and ratio of TG to high density lip...

Full description

Saved in:
Bibliographic Details
Main Authors: Shih-Wei Wang, Tsun-Mei Lin, Chiou-Huey Wang, Hsiao-Han Liu, Jer-Yiing Houng
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2012/690525
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551498965319680
author Shih-Wei Wang
Tsun-Mei Lin
Chiou-Huey Wang
Hsiao-Han Liu
Jer-Yiing Houng
author_facet Shih-Wei Wang
Tsun-Mei Lin
Chiou-Huey Wang
Hsiao-Han Liu
Jer-Yiing Houng
author_sort Shih-Wei Wang
collection DOAJ
description The close relationship between increased TLR-2 expression in blood monocytes and insulin resistance in RA patients is shown in this study. Traditional risk factors for metabolic disorders, including the waist circumstance, body mass index (BMI), triglyceride (TG), and ratio of TG to high density lipoprotein (HDL) cholesterol, were closely correlated with HOMA (homoeostasis model assessment) index in patients with nondiabetic RA. Expressions of TLR2 in peripheral blood monocytes, following stimulation with peptidoglycan which is known as a TLR2 agonist, were closely correlated with the HOMA index, TNF-α, and IL-6 concentrations. Accordingly, TLR-2 receptor and its related inflammatory cytokines could be potential therapeutic targets in managing insulin resistance in RA patients.
format Article
id doaj-art-df3688c2f53f4a43bd0594f4ff1867d9
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-df3688c2f53f4a43bd0594f4ff1867d92025-02-03T06:01:28ZengWileyMediators of Inflammation0962-93511466-18612012-01-01201210.1155/2012/690525690525Increased Toll-Like Receptor 2 Expression in Peptidoglycan-Treated Blood Monocytes Is Associated with Insulin Resistance in Patients with Nondiabetic Rheumatoid ArthritisShih-Wei Wang0Tsun-Mei Lin1Chiou-Huey Wang2Hsiao-Han Liu3Jer-Yiing Houng4Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, E-DA Hospital, No. 1 Yida Road, Yanchao District, Kaohsiung 82445, TaiwanDepartment of Medical Laboratory, E-DA Hospital and I-Shou University, No. 1 Yida Road, Yanchao District, Kaohsiung 82445, TaiwanDepartment of Medical Laboratory, E-DA Hospital and I-Shou University, No. 1 Yida Road, Yanchao District, Kaohsiung 82445, TaiwanDepartment of Biological Science and Technology, I-Shou University, No. 8 Yida Road, Yanchao District, Kaohsiung 82445, TaiwanInstitute of Biotechnology and Chemical Engineering, I-Shou University, Section 1, No. 1 Syuecheng Road, Dashu District, Kaohsiung 84001, TaiwanThe close relationship between increased TLR-2 expression in blood monocytes and insulin resistance in RA patients is shown in this study. Traditional risk factors for metabolic disorders, including the waist circumstance, body mass index (BMI), triglyceride (TG), and ratio of TG to high density lipoprotein (HDL) cholesterol, were closely correlated with HOMA (homoeostasis model assessment) index in patients with nondiabetic RA. Expressions of TLR2 in peripheral blood monocytes, following stimulation with peptidoglycan which is known as a TLR2 agonist, were closely correlated with the HOMA index, TNF-α, and IL-6 concentrations. Accordingly, TLR-2 receptor and its related inflammatory cytokines could be potential therapeutic targets in managing insulin resistance in RA patients.http://dx.doi.org/10.1155/2012/690525
spellingShingle Shih-Wei Wang
Tsun-Mei Lin
Chiou-Huey Wang
Hsiao-Han Liu
Jer-Yiing Houng
Increased Toll-Like Receptor 2 Expression in Peptidoglycan-Treated Blood Monocytes Is Associated with Insulin Resistance in Patients with Nondiabetic Rheumatoid Arthritis
Mediators of Inflammation
title Increased Toll-Like Receptor 2 Expression in Peptidoglycan-Treated Blood Monocytes Is Associated with Insulin Resistance in Patients with Nondiabetic Rheumatoid Arthritis
title_full Increased Toll-Like Receptor 2 Expression in Peptidoglycan-Treated Blood Monocytes Is Associated with Insulin Resistance in Patients with Nondiabetic Rheumatoid Arthritis
title_fullStr Increased Toll-Like Receptor 2 Expression in Peptidoglycan-Treated Blood Monocytes Is Associated with Insulin Resistance in Patients with Nondiabetic Rheumatoid Arthritis
title_full_unstemmed Increased Toll-Like Receptor 2 Expression in Peptidoglycan-Treated Blood Monocytes Is Associated with Insulin Resistance in Patients with Nondiabetic Rheumatoid Arthritis
title_short Increased Toll-Like Receptor 2 Expression in Peptidoglycan-Treated Blood Monocytes Is Associated with Insulin Resistance in Patients with Nondiabetic Rheumatoid Arthritis
title_sort increased toll like receptor 2 expression in peptidoglycan treated blood monocytes is associated with insulin resistance in patients with nondiabetic rheumatoid arthritis
url http://dx.doi.org/10.1155/2012/690525
work_keys_str_mv AT shihweiwang increasedtolllikereceptor2expressioninpeptidoglycantreatedbloodmonocytesisassociatedwithinsulinresistanceinpatientswithnondiabeticrheumatoidarthritis
AT tsunmeilin increasedtolllikereceptor2expressioninpeptidoglycantreatedbloodmonocytesisassociatedwithinsulinresistanceinpatientswithnondiabeticrheumatoidarthritis
AT chiouhueywang increasedtolllikereceptor2expressioninpeptidoglycantreatedbloodmonocytesisassociatedwithinsulinresistanceinpatientswithnondiabeticrheumatoidarthritis
AT hsiaohanliu increasedtolllikereceptor2expressioninpeptidoglycantreatedbloodmonocytesisassociatedwithinsulinresistanceinpatientswithnondiabeticrheumatoidarthritis
AT jeryiinghoung increasedtolllikereceptor2expressioninpeptidoglycantreatedbloodmonocytesisassociatedwithinsulinresistanceinpatientswithnondiabeticrheumatoidarthritis